| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2011 | CN101591348B Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof |
| 07/27/2011 | CN101559065B Choerospondias extractive, preparation and application of phenol compound contained in choerospondias extractive |
| 07/27/2011 | CN101549093B Child throat and tonsil particles |
| 07/27/2011 | CN101541766B Pyrimidyl derivatives as protein kinase inhibitors |
| 07/27/2011 | CN101538268B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101537010B Eyedrop preparation and preparation method thereof |
| 07/27/2011 | CN101518574B Anti-human papilloma virus (anti-HPV) external effervescent tablet and preparation method and application thereof |
| 07/27/2011 | CN101518520B Framework-type transdermal patch with dextro ketoprofen accumulated in subcutaneous deep tissues |
| 07/27/2011 | CN101502499B Ibuprofen percutaneous release patch and preparation method thereof |
| 07/27/2011 | CN101497653B Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 07/27/2011 | CN101491641B Traditional Chinese medicine for treating cancer |
| 07/27/2011 | CN101480398B Use of ivabradine for the treatment of endothelial dysfunction |
| 07/27/2011 | CN101474246B Pharmaceutical composition for enhancing immunity of fowl and coordinating with vaccine for synergy |
| 07/27/2011 | CN101472900B Therapeutic or prophylactic agent for multiple sclerosis |
| 07/27/2011 | CN101468197B Medicament for treating tumor |
| 07/27/2011 | CN101466691B Substituted carboxamides as group I metabotropic receptor antagonists |
| 07/27/2011 | CN101460460B Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists |
| 07/27/2011 | CN101450051B Monomer salvianolic acid B injection and preparation method thereof |
| 07/27/2011 | CN101445541B N-(methylthio-sulfur carbonyl)-17-steroidal hydrazone compound, preparation and application thereof |
| 07/27/2011 | CN101433655B Chinese medicinal composition for treating colpitis |
| 07/27/2011 | CN101417126B New use of OMI protein and coding gene thereof |
| 07/27/2011 | CN101406533B Chinese medicine for treating and preventing hyperpyrexia and pestilence of livestock |
| 07/27/2011 | CN101401941B Preparation and uses of tumor-targeted carrier material RGD-fatty alcohol series of compounds |
| 07/27/2011 | CN101394866B Stabilizer for hydrophobic compounds |
| 07/27/2011 | CN101390835B Ribavirin soluble powder |
| 07/27/2011 | CN101385822B Medicine for mainly treating crural ulcer and preparation method thereof |
| 07/27/2011 | CN101385714B Preparation method of DHA lipid nano-particles |
| 07/27/2011 | CN101380311B Diabecron sustained-release tablet and preparation method thereof |
| 07/27/2011 | CN101371846B Liquid medicine for curing burn and preparation method thereof |
| 07/27/2011 | CN101371831B Use of Fructus arctii aglycone in medicament for killing ectoparasite of aquatic animal |
| 07/27/2011 | CN101367716B Carbon shell bacterium polyketone, preparation and uses thereof |
| 07/27/2011 | CN101366712B Method for preparing fat-soluble vitamin for injection |
| 07/27/2011 | CN101361890B Traditional Chinese medicine formulation for treating radioactivity skin impairment |
| 07/27/2011 | CN101361771B Compound paclitaxel-oleum fructus bruceae injection emulsion and preparation method thereof |
| 07/27/2011 | CN101361741B New anti-tumor use of iso-oxazoline derivates |
| 07/27/2011 | CN101357130B Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 07/27/2011 | CN101348492B Ceftizoxime sodium and preparation thereof |
| 07/27/2011 | CN101347412B Amifostine trihydrate crystal lyophilized preparation and method of preparing the same |
| 07/27/2011 | CN101342250B Bolus for clearing away heat of the upper part of the body |
| 07/27/2011 | CN101333241B Process for extracting dioscin, preparation thereof and use |
| 07/27/2011 | CN101317837B Effective component of rabdosia, preparation method and application thereof |
| 07/27/2011 | CN101316816B Serotonin transporter (SERT) inhibitors |
| 07/27/2011 | CN101307078B Galactosyl thiourea heterocyclic compounds, synthetic method thereof and antineoplastic applications |
| 07/27/2011 | CN101306001B Use of 2'-O-beta-D-glucopyranose-momordin Ic or plant extract containing same in preparing alpha-glucosidase inhibitor or invertase inhibitor |
| 07/27/2011 | CN101296703B Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 07/27/2011 | CN101296691B Transdermal drug delivery formulation |
| 07/27/2011 | CN101282977B Xanthine derivatives as selective hm74a agonists |
| 07/27/2011 | CN101273034B Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/27/2011 | CN101244234B Medicaments for preventing and controlling ischemia and hemorrhagic cerebrovaseular disease, and preparation thereof |
| 07/27/2011 | CN101229130B Isomorellic acid polylactic acid nano particle preparation and preparing method thereof |
| 07/27/2011 | CN101220375B Fowl pox virus double-gene expression carrier (PT7.5N) |
| 07/27/2011 | CN101214275B Compound red sage root extended release formulation and preparation thereof |
| 07/27/2011 | CN101205218B Substituted cinnamyl piperazine as well as preparation and uses thereof |
| 07/27/2011 | CN101199576B Medicament prescription for treating coronary heart disease |
| 07/27/2011 | CN101193885B Benzofuran derivative as 5-HT6 receptor inhibitor |
| 07/27/2011 | CN101193642B Nucleotide analogue prodrug and the preparation thereof |
| 07/27/2011 | CN101181337B High ester catechin capsule for curing mammary cancer and preparation method thereof |
| 07/27/2011 | CN101180050B Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 07/27/2011 | CN101180036B Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/27/2011 | CN101175491B Use of a sulfonamide compound for improving the pharmacokinetics of a drug |
| 07/27/2011 | CN101173275B Small interfering RNA for restraining SARS corona virus M protein gene expression, encoding gene and application thereof |
| 07/27/2011 | CN101161670B Ursolic acid chemical modified compound amine having antitumor activity |
| 07/27/2011 | CN101160297B 2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (IAP) modulators |
| 07/27/2011 | CN101155816B (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as HIV viral replication inhibitors |
| 07/27/2011 | CN101143165B Composition containing cistanche tubulosa and its extract for treating osteoporosis |
| 07/27/2011 | CN101137381B Pharmaceutical use of 2-anilino-3,4-dihydro-quinazolines as 5HT5a receptor antagonists |
| 07/27/2011 | CN101129598B Medicament for treating chronic pharyngitis |
| 07/27/2011 | CN101094835B Novel dicarboxamide derivatives |
| 07/27/2011 | CN101094687B Nutritional composition comprising immunoglobulin and oligosaccharides |
| 07/27/2011 | CN101087795B Pharmaceutical compounds |
| 07/27/2011 | CN101076525B Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| 07/27/2011 | CN101067146B Biological extraction process of glycyrrhizic acid |
| 07/27/2011 | CN101065391B C-aryl glucoside sglt2 inhibitors and method |
| 07/27/2011 | CN101065377B Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto |
| 07/27/2011 | CN101062167B Preparing method of Chinese medicine composition for treating gynecopathy |
| 07/27/2011 | CN101054554B Composition for increasing microorganism wall permeability and method for detecting said microorganisms on a membrane |
| 07/27/2011 | CN101052384B Non-aqueous transdermal absorption preparation containing non-steroid antiphlogistic analgesic |
| 07/27/2011 | CN101045062B Polyenephophatidylcholine enteric coated preparation, its preparing method and application |
| 07/27/2011 | CN101039963B Biotinylated hexadecasaccharides, preparation and use thereof |
| 07/27/2011 | CN101039699B Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 07/27/2011 | CN101037641B Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
| 07/27/2011 | CN101031557B Substituted quinolones |
| 07/27/2011 | CN101027059B Combination comprising ZD6474 and imatinib and pharmaceutical uses thereof |
| 07/27/2011 | CN101018567B Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 07/27/2011 | CN101010297B N-(1h-indolyl)-1h-indole-2-carboxamide derivatives, their preparation and their therapeutic use |
| 07/27/2011 | CA2732488A1 Microspheres useful for therapeutic vascular embolization |
| 07/27/2011 | CA2690877A1 Preventing canker sores |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985865 absorbs light from the visible wavelength range and is soluble in a phase change ink; new colorants with substantial hydrophobic character |
| 07/26/2011 | US7985861 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 07/26/2011 | US7985859 Processes for the preparation of clopidogrel |
| 07/26/2011 | US7985853 RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA) |
| 07/26/2011 | US7985848 Antidiabetic agent, blood glucose control abnormality; ginsenosides Rg3, Rg5, and Rk1 from natural substances |
| 07/26/2011 | US7985844 Antibody that specifically binds hyaluronan synthase |
| 07/26/2011 | US7985776 charged curcuminoid such as bisdemethoxycurcumin, curcumin and glycinates, as well as hybrid compounds of bisdemethoxycurcumin and resveratrol, fisetin, or honokiol; bioavailability |
| 07/26/2011 | US7985775 Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals |
| 07/26/2011 | US7985774 Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug |
| 07/26/2011 | US7985772 Derivatives of 3,3-diphenylpropylamines |
| 07/26/2011 | US7985771 Furanone derivatives |